Technology News and Research

RSS

Roundup: Abortion restriction measure goes to Kan. governor's desk

Kansas legislators gave final passage to a sweeping anti-abortion measure Friday night, sending Gov. Sam Brownback a bill that declares life begins "at fertilization" while blocking tax breaks for abortion providers and banning abortions performed solely because of the baby's sex.

9 Apr 2013

Study offers new insights into how nervous system processes hot and cold temperatures

A study from the University of North Carolina School of Medicine offers new insights into how the nervous system processes hot and cold temperatures. The research led by neuroscientist Mark J. Zylka, PhD, associate professor of cell biology and physiology, found an interaction between the neural circuits that detect hot and cold stimuli: cold perception is enhanced when nerve circuitry for heat is inactivated.

9 Apr 2013

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.

9 Apr 2013

Blood test reveals more gene mutations in cancer than traditional tumor biopsy

A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.

8 Apr 2013

Spectrum Pharmaceuticals begins Phase 2 clinical program for SPI-2012

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the Company has initiated a Phase 2 clinical program for SPI-2012 (also referred to as "LAPS-GCSF"), a drug candidate for the treatment of chemotherapy-induced neutropenia that utilizes partner Hanmi Pharmaceutical Company's proprietary LAPSCOVERY™ Technology.

8 Apr 2013

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.

8 Apr 2013

First Edition: April 8, 2013

Today's headlines include reports about the politics surrounding the Wednesday unveiling of President Barack Obama's budget as well as other news about the health law's implementation.

8 Apr 2013

Facial plastic surgeon adds Pelleve Wrinkle Reduction System into Main Line Center for Laser Surgery

Facial plastic and reconstructive surgeon Dr. Jason D. Bloom knows anti-aging. That's why he's just introduced the Pelleve Wrinkle Reduction System into the Main Line Center for Laser Surgery where he's committed to helping patients look their best.

8 Apr 2013

Lipocine announces favorable Phase I study results for LPCN 1111

Lipocine Inc., a biopharmaceutical company focused on developing innovative oral hormone therapies for men's and women's health, today announced favorable Phase I results for LPCN 1111.

8 Apr 2013

DPRx signs first license for Online, Real-Time Insurer Authorization system

DPRx's CEO, John Discola , announced the signing of the first license for PRO/3G its recently released Online, Real-Time Insurer Authorization system.

8 Apr 2013

Scientists reveal mystery of how arsenic levels in beer sold in Germany

The mystery of how arsenic levels in beer sold in Germany could be higher than in the water or other ingredients used to brew the beer has been solved, scientists announced here today at the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

8 Apr 2013

Business Network Services from Anglia Ruskin: an interview with Prof Young

The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.

8 Apr 2013

Nine Nobel laureates to present their research at American Chemical Society meeting

At least nine Nobel laureates have research that will be presented here this week during the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

8 Apr 2013

New Orleans to host scientific conference on energy and food

Renowned for its cuisine and chefs and as a global hub of the energy industry, New Orleans this week hosts what news media have described as the "World Series of Science," one of the year's largest and most important scientific conferences.

8 Apr 2013

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).

8 Apr 2013

GenSight Biologics announces closing of €32 million Series A financing

GenSight Biologics, a biopharmaceutical company focused on the development of ophthalmic therapeutics using gene therapy, announced today the closing of a €32 million Series A financing.

8 Apr 2013

Pros and cons of new screening technologies for breast cancer

Although mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, it has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation.

8 Apr 2013

Technology News and Research

Roundup: Abortion restriction measure goes to Kan. governor's desk

Study offers new insights into how nervous system processes hot and cold temperatures

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Blood test reveals more gene mutations in cancer than traditional tumor biopsy

Spectrum Pharmaceuticals begins Phase 2 clinical program for SPI-2012

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

First Edition: April 8, 2013

Facial plastic surgeon adds Pelleve Wrinkle Reduction System into Main Line Center for Laser Surgery

Lipocine announces favorable Phase I study results for LPCN 1111

DPRx signs first license for Online, Real-Time Insurer Authorization system

Scientists reveal mystery of how arsenic levels in beer sold in Germany

Business Network Services from Anglia Ruskin: an interview with Prof Young

Nine Nobel laureates to present their research at American Chemical Society meeting

New Orleans to host scientific conference on energy and food

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

GenSight Biologics announces closing of €32 million Series A financing

Pros and cons of new screening technologies for breast cancer

MentisCura launches clinical center for early detection of Alzheimer's disease, dementia

Fruit-juice-infused chocolate offers healthy treat

Nektar Therapeutics presents positive results for NKTR-214 at AACR Annual Meeting

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News